Young Lung Cancer Program

Contact the Young Lung Cancer Program 

Referring physicians: 617-632-6875
All other inquiries: 617-632-5301
Fax: 617-632-4413

For general inquiries, email younglungcancerprogram
@dfci.harvard.edu.

For urgent or clinical concerns, contact your care team.

The Young Lung Cancer Program at Dana-Farber offers expert, compassionate care and support to young adults living with lung cancer.

We bring together specialists in thoracic (lung) cancer, genetics, supportive care, and survivorship. Our goal is to help you and your family feel supported, informed, and empowered throughout every step of care.

We also work to improve care for younger adults through research. Our team studies risk factors, genetic mutations, and other causes of young-onset lung cancer. What we learn helps us find better, more personalized ways to diagnose and treat lung cancer — and helps more people get the right care at the right time.

Care for the Whole Person

Lung cancer affects more than your body. It can also affect work, relationships, fertility, finances, and mental health. We help with both the medical and everyday parts of care.

Our team can provide you with:

  • Tumor genetic (molecular) testing to help match treatment to the cancer’s genes
  • Genetic counseling and testing (inherited risk) when appropriate
  • Clinical trials of new therapies for lung cancer
  • Fertility, family planning, and sexual health support
  • Psychosocial care, including counseling and emotional support
  • Survivorship planning and peer connection opportunities
  • Integrative therapies to support well-being during care (as available)

Support for Adults Diagnosed Before 50

Lung Cancer Under 50

Lung cancer is more commonly diagnosed later in life. Under 50, it can be harder to recognize, and younger adults may face delays in diagnosis and concerns about fertility, parenting, work, and long-term health.

Support and Resources

The Young Lung Cancer Program helps you manage care while staying focused on your personal, work, and family goals. We support both the medical and emotional parts of treatment—from diagnosis through recovery and life beyond cancer.

Research and Clinical Trials

Research is a key part of the Young Lung Cancer Program. Our goal is to understand why lung cancer happens in younger adults and to develop better ways to diagnose, treat, and support patients.

Program Leadership

Narjust Florez, MD
Co-Founder and Co-Director

Dr. Florez focuses on clinical care and research for young adults with lung cancer, including outcomes and the emotional and practical needs of patients and families.

Jaclyn LoPiccolo, MD, PhD 
Co-Founder and Co-Director

Dr. LoPiccolo works in thoracic oncology and cancer genetics. Her research focuses on the genetic drivers of young-onset lung cancer and how to translate findings into better screening, prevention, and treatment.